FR6368M - - Google Patents
Info
- Publication number
- FR6368M FR6368M FR84447A FR84447A FR6368M FR 6368 M FR6368 M FR 6368M FR 84447 A FR84447 A FR 84447A FR 84447 A FR84447 A FR 84447A FR 6368 M FR6368 M FR 6368M
- Authority
- FR
- France
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US327070A US3296255A (en) | 1963-11-29 | 1963-11-29 | 2-cyano steroids |
NL6616225A NL6616225A (fr) | 1963-11-29 | 1966-11-17 | |
FR84447A FR6368M (fr) | 1963-11-29 | 1966-11-22 | |
BE690024D BE690024A (fr) | 1963-11-29 | 1966-11-22 | |
DE1966ST026144 DE1593564B2 (de) | 1963-11-29 | 1966-11-23 | 2 alpha-cyan-4 alpha, 5 alpha-epoxy3-oxoandrostane und verfahren zu ihrer herstellung |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US327070A US3296255A (en) | 1963-11-29 | 1963-11-29 | 2-cyano steroids |
GB5123166A GB1123770A (en) | 1966-11-15 | 1966-11-15 | 2-cyano-3-oxo-steroids |
NL6616225A NL6616225A (fr) | 1963-11-29 | 1966-11-17 | |
FR84447A FR6368M (fr) | 1963-11-29 | 1966-11-22 | |
DE1966ST026144 DE1593564B2 (de) | 1963-11-29 | 1966-11-23 | 2 alpha-cyan-4 alpha, 5 alpha-epoxy3-oxoandrostane und verfahren zu ihrer herstellung |
CH1688066A CH485693A (de) | 1966-11-24 | 1966-11-24 | Verfahren zur Herstellung von 2a-Cyan-4a,5a-epoxy-3-oxo-steroiden |
Publications (1)
Publication Number | Publication Date |
---|---|
FR6368M true FR6368M (fr) | 1968-10-14 |
Family
ID=27543910
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR84447A Expired FR6368M (fr) | 1963-11-29 | 1966-11-22 |
Country Status (5)
Country | Link |
---|---|
US (1) | US3296255A (fr) |
BE (1) | BE690024A (fr) |
DE (1) | DE1593564B2 (fr) |
FR (1) | FR6368M (fr) |
NL (1) | NL6616225A (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2412569A1 (fr) * | 1977-12-20 | 1979-07-20 | Sterling Drug Inc | Steroides, leur preparation et leur utilisation therapeutique |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3980638A (en) * | 1974-09-20 | 1976-09-14 | The Upjohn Company | Testosterone derivatives |
US4029776A (en) * | 1975-12-19 | 1977-06-14 | Sterling Drug Inc. | Therapeutic composition and method of use thereof |
US4062954A (en) * | 1976-12-27 | 1977-12-13 | Sterling Drug Inc. | Process for using a steroid compound |
US4115563A (en) * | 1977-03-14 | 1978-09-19 | Sterling Drug Inc. | Pharmaceutical steroid formulation |
US4395423A (en) * | 1978-10-10 | 1983-07-26 | Sterling Drug Inc. | Polycyclic cyanoketones |
US4331663A (en) * | 1981-06-19 | 1982-05-25 | Sterling Drug Inc. | 4α,5α-Epoxy-3,20-dioxopregnane-2α,16α-dicarbonitrile and intermediates and process for preparation, method of use and compositions thereof |
US4349474A (en) * | 1981-07-27 | 1982-09-14 | G. D. Searle & Co. | 2-Cyanosteroids |
US4388311A (en) * | 1982-05-06 | 1983-06-14 | G. D. Searle & Co. | Method for the induction of menses |
JPS5995300A (ja) | 1982-11-02 | 1984-06-01 | スタ−リング・ドラッグ・インコ−ポレ−テッド | コントロ−ルされた粒度の2−シアノ−4,5−エポキシ−3−オキソ−ステロイド類およびそれらの組成物 |
US4459235A (en) * | 1983-03-03 | 1984-07-10 | G. D. Searle & Co. | 2-Cyanosteroids |
US4755595A (en) * | 1985-11-01 | 1988-07-05 | Sterling Drug Inc. | Enhanced production of 4,5-unsaturated steroids utilizing methanol solvation |
GB2375958B (en) * | 2001-04-09 | 2005-03-02 | George Margetts | The use of steroids to lower the levels of cortisol |
GB2400554B (en) * | 2003-04-16 | 2007-04-18 | George Margetts | Treatment of angiotensin II-induced cardiovascular disease |
GB2414238B (en) * | 2004-05-22 | 2006-12-13 | Stegram Pharmaceuticals Ltd | Method for the preparation of trilostane |
EP2446887A3 (fr) | 2005-07-12 | 2012-08-15 | DMI Biosciences, Inc. | Utilisation du danazol pour le traitement de la maladie de Alzheimer |
US20190224214A1 (en) * | 2016-08-16 | 2019-07-25 | Syracuse University | Human ghrelin o-acyltransferase inhibitors |
CN115028674A (zh) * | 2022-06-01 | 2022-09-09 | 山东沾化浩瀚药业有限公司 | 一种乳腺癌治疗药物曲洛司坦的制备方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3035051A (en) * | 1960-09-12 | 1962-05-15 | American Cyanamid Co | 2alpha-cyano or 2-hydroxymethylene-3-keto steroids |
US3198790A (en) * | 1962-05-12 | 1965-08-03 | Ormonoterapia Richter Spa | Steroidal dipyrimidines |
-
1963
- 1963-11-29 US US327070A patent/US3296255A/en not_active Expired - Lifetime
-
1966
- 1966-11-17 NL NL6616225A patent/NL6616225A/xx unknown
- 1966-11-22 BE BE690024D patent/BE690024A/xx not_active IP Right Cessation
- 1966-11-22 FR FR84447A patent/FR6368M/fr not_active Expired
- 1966-11-23 DE DE1966ST026144 patent/DE1593564B2/de active Granted
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2412569A1 (fr) * | 1977-12-20 | 1979-07-20 | Sterling Drug Inc | Steroides, leur preparation et leur utilisation therapeutique |
Also Published As
Publication number | Publication date |
---|---|
DE1593564B2 (de) | 1976-04-22 |
NL6616225A (fr) | 1968-05-20 |
BE690024A (fr) | 1967-05-22 |
DE1593564A1 (de) | 1970-08-13 |
US3296255A (en) | 1967-01-03 |